HCP Connect Contributor
Dr. Anjali Mehta
Dr. Anjali Mehta contributes radiology drug update coverage for HCP Connect, with emphasis on source-verified therapeutic developments and practical clinical context for US-licensed practitioners. This profile links the author's recent clinical coverage, specialty focus, and professional contributor metadata in one place.
Recent Drug Updates
7 total
Digital Health
Harnessing Digital Health Platforms for Enhanced Remote Patient Monitoring
Explore the rise of digital health platforms for remote patient monitoring and their impact on patient care and healthcare delivery.
Medical Opinion
Build Trust, Boost Leadership
Learn how to establish strong dyad leadership through effective communication and trust-building strategies to improve healthcare outcomes and teamwork.
Healthcare Business
Boost Rural Health Outcomes by 30%
Discover how a $50 billion initiative aims to close care gaps and improve health outcomes in rural areas through innovative access points and preventative care.
Medical Research
Boosts ICB Response via STING Activation
Discover how CDK12/13 inactivation improves immune checkpoint blockade response in prostate cancer through enhanced STING activation and tumor-specific T cell enrichment.
Medical Research
Inhibiting VEGFR2 May Reduce Angiogenesis by 30%
Discover how AIP1 regulates vascular endothelial cell apoptosis and angiogenesis, and its potential impact on inflammatory angiogenesis models and VEGF-VEGFR2 signaling.
Medical Research
Opioids in Pregnancy: No Link to Autism, ADHD
New study finds opioid exposure in utero may not increase risk of autism or ADHD in children, easing concerns for pregnant patients and prescribing physicians.
Healthcare Business
Cemiplimab Plus Chemo Boosts NSCLC Survival
New 5-year data from the EMPOWER-Lung 3 trial shows cemiplimab plus chemotherapy improves overall survival in non-small cell lung cancer patients compared to chemo alone.